P08913 ADA2A_HUMAN

Gene name: ADRA2A
Protein name: Alpha-2A adrenergic receptor

List of molecules and drugs that target protein P08913
# DrugDomain Data DrugBank Accession Name Drug action Affinity data InChI Key SMILES
1 P08913_DB00246 DB00246 Ziprasidone antagonist Ki(nM) = 154.0
MVWVFYHBGMAFLY-UHFFFAOYSA-N ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
2 P08913_DB00248 DB00248 Cabergoline antagonist
KORNTPPJEAJQIU-KJXAQDMKSA-N [H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
3 P08913_DB00320 DB00320 Dihydroergotamine agonist
LUZRJRNZXALNLM-JGRZULCMSA-N [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
4 P08913_DB00321 DB00321 Amitriptyline antagonist Ki(nM) = 114.0
KRMDCWKBEZIMAB-UHFFFAOYSA-N CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
5 P08913_DB00363 DB00363 Clozapine antagonist Ki(nM) = 24.0
QZUDBNBUXVUHMW-UHFFFAOYSA-N CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
6 P08913_DB00368 DB00368 Norepinephrine agonist Ki(nM) = 30.0
EC50(nM) = 110.0
SFLSHLFXELFNJZ-QMMMGPOBSA-N NC[C@H](O)C1=CC(O)=C(O)C=C1
7 P08913_DB00370 DB00370 Mirtazapine antagonist Ki(nM) = 20.0
IC50(nM) = 85.0
RONZAEMNMFQXRA-UHFFFAOYSA-N CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
8 P08913_DB00408 DB00408 Loxapine binder Ki(nM) = 150.8
XJGVXQDUIWGIRW-UHFFFAOYSA-N CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
9 P08913_DB00413 DB00413 Pramipexole agonist Ki(nM) = 76.0
FASDKYOPVNHBLU-ZETCQYMHSA-N CCCN[C@H]1CCC2=C(C1)SC(N)=N2
10 P08913_DB00449 DB00449 Dipivefrin agonist
OCUJLLGVOUDECM-UHFFFAOYSA-N CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
11 P08913_DB00457 DB00457 Prazosin binder Ki(nM) = 210.0
IENZQIKPVFGBNW-UHFFFAOYSA-N COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
12 P08913_DB00484 DB00484 Brimonidine agonist Ki(nM) = 1.4
IC50(nM) = 3.0
EC50(nM) = 0.616595
XYLJNLCSTIOKRM-UHFFFAOYSA-N BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
13 P08913_DB00502 DB00502 Haloperidol n/a Ki(nM) = 600.0
LNEPOXFFQSENCJ-UHFFFAOYSA-N OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
14 P08913_DB00543 DB00543 Amoxapine antagonist
QWGDMFLQWFTERH-UHFFFAOYSA-N ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
15 P08913_DB00555 DB00555 Lamotrigine inhibitor
PYZRQGJRPPTADH-UHFFFAOYSA-N NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
16 P08913_DB00575 DB00575 Clonidine agonist
GJSURZIOUXUGAL-UHFFFAOYSA-N ClC1=CC=CC(Cl)=C1NC1=NCCN1
17 P08913_DB00589 DB00589 Lisuride other/unknown
BKRGVLQUQGGVSM-KBXCAEBGSA-N [H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
18 P08913_DB00629 DB00629 Guanabenz agonist Ki(nM) = 21.88
WDZVGELJXXEGPV-YIXHJXPBSA-N NC(N)=NN=CC1=C(Cl)C=CC=C1Cl
19 P08913_DB00633 DB00633 Dexmedetomidine agonist
CUHVIMMYOGQXCV-NSHDSACASA-N C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
20 P08913_DB00656 DB00656 Trazodone antagonist Ki(nM) = 106.0
PHLBKPHSAVXXEF-UHFFFAOYSA-N ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
21 P08913_DB00668 DB00668 Epinephrine agonist Ki(nM) = 5.0
IC50(nM) = 8.0
EC50(nM) = 30.0
UCTWMZQNUQWSLP-VIFPVBQESA-N CNC[C@H](O)C1=CC(O)=C(O)C=C1
22 P08913_DB00692 DB00692 Phentolamine antagonist Ki(nM) = 1.58
MRBDMNSDAVCSSF-UHFFFAOYSA-N CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
23 P08913_DB00696 DB00696 Ergotamine partial agonist
XCGSFFUVFURLIX-VFGNJEKYSA-N [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
24 P08913_DB00714 DB00714 Apomorphine agonist Ki(nM) = 141.25
VMWNQDUVQKEIOC-CYBMUJFWSA-N [H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
25 P08913_DB00726 DB00726 Trimipramine antagonist
ZSCDBOWYZJWBIY-UHFFFAOYSA-N CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
26 P08913_DB00751 DB00751 Epinastine unknown
WHWZLSFABNNENI-UHFFFAOYSA-N NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
27 P08913_DB00797 DB00797 Tolazoline antagonist Ki(nM) = 24.0
JIVZKJJQOZQXQB-UHFFFAOYSA-N C(C1=NCCN1)C1=CC=CC=C1
28 P08913_DB00800 DB00800 Fenoldopam antagonist Ki(nM) = 16.0
TVURRHSHRRELCG-UHFFFAOYSA-N OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
29 P08913_DB00852 DB00852 Pseudoephedrine agonist
KWGRBVOPPLSCSI-WCBMZHEXSA-N CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
30 P08913_DB00865 DB00865 Benzphetamine agonist
YXKTVDFXDRQTKV-HNNXBMFYSA-N C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
31 P08913_DB00925 DB00925 Phenoxybenzamine antagonist
QZVCTJOXCFMACW-UHFFFAOYSA-N CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
32 P08913_DB00935 DB00935 Oxymetazoline agonist Ki(nM) = 0.79
EC50(nM) = 3.3
WYWIFABBXFUGLM-UHFFFAOYSA-N CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
33 P08913_DB00964 DB00964 Apraclonidine agonist Ki(nM) = 7.94
IEJXVRYNEISIKR-UHFFFAOYSA-N NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
34 P08913_DB00968 DB00968 Methyldopa agonist
CJCSPKMFHVPWAR-JTQLQIEISA-N C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O
35 P08913_DB01018 DB01018 Guanfacine agonist Ki(nM) = 50.3
INJOMKTZOLKMBF-UHFFFAOYSA-N NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
36 P08913_DB01136 DB01136 Carvedilol antagonist
OGHNVEJMJSYVRP-UHFFFAOYSA-N COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
37 P08913_DB01149 DB01149 Nefazodone antagonist Ki(nM) = 84.0
VRBKIVRKKCLPHA-UHFFFAOYSA-N CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
38 P08913_DB01200 DB01200 Bromocriptine agonist Ki(nM) = 10.96
OZVBMTJYIDMWIL-AYFBDAFISA-N [H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
39 P08913_DB01224 DB01224 Quetiapine antagonist Ki(nM) = 80.0
URKOMYMAXPYINW-UHFFFAOYSA-N OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
40 P08913_DB01238 DB01238 Aripiprazole antagonist Ki(nM) = 74.0
CEUORZQYGODEFX-UHFFFAOYSA-N ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
41 P08913_DB01267 DB01267 Paliperidone antagonist Ki(nM) = 30.0
PMXMIIMHBWHSKN-UHFFFAOYSA-N CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
42 P08913_DB01392 DB01392 Yohimbine antagonist Ki(nM) = 0.32
IC50(nM) = 3.67
Kd(nM) = 2300.0
EC50(nM) = 8.5
BLGXFZZNTVWLAY-SCYLSFHTSA-N [H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
43 P08913_DB01403 DB01403 Methotrimeprazine antagonist
VRQVVMDWGGWHTJ-CQSZACIVSA-N COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
44 P08913_DB01472 DB01472 4-Methoxyamphetamine agonist
NEGYEDYHPHMHGK-UHFFFAOYSA-N COC1=CC=C(CC(C)N)C=C1
45 P08913_DB01577 DB01577 Metamfetamine agonist
MYWUZJCMWCOHBA-VIFPVBQESA-N CN[C@@H](C)CC1=CC=CC=C1
46 P08913_DB01608 DB01608 Periciazine antagonist
LUALIOATIOESLM-UHFFFAOYSA-N OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1
47 P08913_DB01624 DB01624 Zuclopenthixol antagonist
WFPIAZLQTJBIFN-DVZOWYKESA-N OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
48 P08913_DB04846 DB04846 Celiprolol antagonist
JOATXPAWOHTVSZ-UHFFFAOYSA-N CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
49 P08913_DB04855 DB04855 Dronedarone antagonist
ZQTNQVWKHCQYLQ-UHFFFAOYSA-N CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
50 P08913_DB04948 DB04948 Lofexidine agonist Ki(nM) = 4.4
EC50(nM) = 6.3
KSMAGQUYOIHWFS-UHFFFAOYSA-N CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
51 P08913_DB05492 DB05492 Epicept NP-1 n/a
FKZUPMCBVURANR-UHFFFAOYSA-N CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
52 P08913_DB06148 DB06148 Mianserin antagonist
UEQUQVLFIPOEMF-UHFFFAOYSA-N CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
53 P08913_DB06153 DB06153 Pizotifen antagonist
FIADGNVRKBPQEU-UHFFFAOYSA-N CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
54 P08913_DB06216 DB06216 Asenapine antagonist Ki(nM) = 6.5
VSWBSWWIRNCQIJ-UHFFFAOYSA-N CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1
55 P08913_DB06229 DB06229 Ocaperidone n/a
ZZQNEJILGNNOEP-UHFFFAOYSA-N CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
56 P08913_DB06262 DB06262 Droxidopa agonist
QXWYKJLNLSIPIN-JGVFFNPUSA-N N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
57 P08913_DB06623 DB06623 Flupirtine n/a
JUUFBMODXQKSTD-UHFFFAOYSA-N CCOC(=O)NC1=C(N)N=C(NCC2=CC=C(F)C=C2)C=C1
58 P08913_DB06694 DB06694 Xylometazoline agonist Ki(nM) = 15.14
HUCJFAOMUPXHDK-UHFFFAOYSA-N CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
59 P08913_DB06711 DB06711 Naphazoline agonist Ki(nM) = 20.89
IC50(nM) = 0.0011
CNIIGCLFLJGOGP-UHFFFAOYSA-N C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
60 P08913_DB08815 DB08815 Lurasidone n/a
PQXKDMSYBGKCJA-CVTJIBDQSA-N [H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
61 P08913_DB09242 DB09242 Moxonidine agonist
WPNJAUFVNXKLIM-UHFFFAOYSA-N COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
62 P08913_DB09244 DB09244 Pirlindole antagonist
IWVRVEIKCBFZNF-UHFFFAOYSA-N CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1
63 P08913_DB09286 DB09286 Pipamperone antagonist Ki(nM) = 860.0
AXKPFOAXAHJUAG-UHFFFAOYSA-N NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
64 P08913_DB11278 DB11278 DL-Methylephedrine agonist
FMCGSUUBYTWNDP-ONGXEEELSA-N C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
65 P08913_DB11738 DB11738 Rilmenidine n/a
CQXADFVORZEARL-UHFFFAOYSA-N C1CC1C(NC1=NCCO1)C1CC1
66 P08913_DB14185 DB14185 Aripiprazole lauroxil n/a
DDINXHAORAAYAD-UHFFFAOYSA-N CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12